Serina Therapeutics SER
NYSE SER
$1.51 +0.07 (+4.86%)
At close: Nov 11, 2026 · 4:00 PM EST

Serina Therapeutics (SER) Return on Sales [ROS] (2018 - 2026)

Updated

Serina Therapeutics (SER) recorded Return on Sales [ROS] of -19190.77% in Q2 2026, down 14910.00 percentage points from -4280.77% a year earlier.

Analysis

Serina Therapeutics (SER) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

For FY2025, Serina Therapeutics reported Return on Sales [ROS] of -18478.46%, up 11964.40 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -15680.68 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -30442.86% in FY2024 (-30343.62 pp), -99.24% in FY2023 (+20415.47 pp), -20514.71% in FY2022 (-15005.68 pp) and -5509.03% in FY2021 (-2711.24 pp).
  • Quarterly Return on Sales [ROS] has ranged from -46420.00% in Q1 2024 to 7.81% in Q4 2023 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in four of the last seven quarters, with an average year-over-year change of -5590.85 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 37833.33 percentage points in Q1 2023, against a drop of 43213.33 percentage points in Q1 2024 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Serina Therapeutics 23.59 Mn -35.63 Mn - -20,065.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20,065.38%
Dec 31, 2025 -18,478.46%
Sep 30, 2025 -20,141.38%
Jun 30, 2025 -4,280.77%
Mar 31, 2025 -40,362.75%
Dec 31, 2024 -30,442.86%
Sep 30, 2024 -37,942.86%
Jun 30, 2024 -7,580.39%
Mar 31, 2024 -46,420.00%
Dec 31, 2023 7.81%
Sep 30, 2023 -5,044.83%
Jun 30, 2023 -13,500.00%
Mar 31, 2023 -3,206.67%
Dec 31, 2022 -22,275.00%
Sep 30, 2022 -17,222.22%
Jun 30, 2022 -13,258.33%
Mar 31, 2022 -41,040.00%
Dec 31, 2021 -6,914.81%
Sep 30, 2021 -6,975.00%
Jun 30, 2021 -5,959.46%
API Access

Serina Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SER&period=max&api_key=YOUR_API_KEY